EL
Emily M. Leproust (Chief Executive Officer) filed 21 Form 4 reports in the trailing twelve months (0 purchases, 21 sales), most often in Twist Bioscience Corporation (TWST). The largest single filing was $56.3M of TWST (356,546 sh across 13 lots, as filed), executed Sep 17. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
21
0 buys · 21 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$99.1M
shares × price, as filed
Last traded
Nov 3
Filed Nov 5
Median ADV $206.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $102.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
21 filings
Sector per market data · by filing · past 12 months
Most traded names
TWSTRecent filings
TWSTSALE
Twist Bioscience Corporation
View filing →
$158K5,585 sh × $28.36
Exec Aug 4 2025
Filed Aug 6 2025 · 5:30 PM ET TWSTSALE Twist Bioscience Corporation View filing → $190K
5,042 sh × $37.65
Exec May 5 2025
Filed May 7 2025 · 5:30 PM ET TWSTSALE Twist Bioscience Corporation View filing → $123K
2,790 sh × $44.18
Exec Feb 21 2025
Filed Feb 25 2025 · 5:30 PM ET TWSTSALE Twist Bioscience Corporation View filing → $257K
5,200 sh × $49.35
Exec Feb 3 2025
Filed Feb 5 2025 · 5:30 PM ET